We are fortunate to have three excellent keynote speakers, who will share their unique perspectives on delivering impact for patients and other stakeholders.
Dr Barbara Farrell, Bruyère Research Institute, Ottawa
Developing and Implementing Deprescribing Guidelines - Lessons Learned through Knowledge Mobilization
Dr Barbara Farrell is a pharmacist with the Bruyère Continuing Care Geriatric Day Hospital, and Senior Investigator with the Bruyère Research Institute in Ottawa, Ontario, Canada. She is the lead Canadian researcher for the development of evidence-based deprescribing guidelines and hosts the deprescribing.org website. Dr Farrell is a co-founder of the Canadian Deprescribing Network, is a member of the Scientific Advisory Board of the United States Deprescribing Research Network, has been a Canadian Pharmacists Association Pharmacist of the Year and is a recent recipient of the CIHR Betty Havens Prize for Knowledge Translation in Aging.
Dr Farrell will discuss her team’s experience with engaging stakeholders and users to promote the uptake and impact of deprescribing guidelines. She will highlight how this research and knowledge has influenced and contributed to change in how people approach deprescribing and what difference this has made.
Professor Mahendra Patel, University of Bradford
Professor Patel will describe how pharmacy made an impact in the PRINCIPLE COVID-19 clinical trial.
Ade Williams, MJ Williams Pharmacy Group
Mr Williams will discuss how researchers can work with practising pharmacists to achieve impact.